Elastases and Elastin Degradation  by Werb, Zena et al.
0022-202Xj82j7901-154s$02.00jO 
THE ,JOURNAL OF INVESTIGATIVE DERMATOLOGY, 79:1548-1598,1982 
Copyright © 1982 by The Williams & Wilkins Co. 
Vol. 79, Supplement 1 
Printed in U.S.A. 
Elastases and Elastin Degradation 
ZENA WERB, PH.D., MICHAEL J. RANDA, PH.D., JAMES H. McKERROW, M.D., PH.D., AND 
ROBERT A. SANDHAUS, M.D., PH.D. 
Laboratory of Radiobiology and /<:nuironmental Health (ZW, MJB, RAS) and the Department., of Anatomy (ZW) and Pathology (JHM), 
Uniuersity of California, San Francisco, California, U.S.A. 
The metabolic turnover of mature elastin fibers in 
adult animals is relatively slow. Although only small 
amounts of elastin are degraded normally, increased 
degradation and fragmentation of elastic fibers may play 
a significant role in disease processes. Elastinolytic en­
zymes are found in microorganisms, snake venoms, and 
in a number of mammalian cells and tissues, including 
pancreas, polymorphonuclear leukocytes, and macro­
phages. Elastinolytic enzymes fall into all 4 classes of 
proteinases (aspartic, cysteine, serine, and metallo) and 
show a spectrum of different specificities. All elastases 
studied to date have catalytic activity against protein 
and peptide substrates other than elastin. The presence 
of elastase activity is a virulence factor associated with 
the pathogenicity of Pseudomonas and other bacteria, 
dermatophytic fungi, and necrosis by rattlesnake ven­
oms. Only elastinolytic enzymes are capable of inducing 
experimental pulmonary emphysema. Elastin degrada­
tion mediated by living macrophages and trophoblasts 
is confined to the immediate pericellular environment. 
Destruction of mature elastin by other mammalian elas­
tases is probably the result of an imbalance in the normal 
inhibitor-proteinase ratio. The major plasma inhibitors 
contributing to the regulatory balance are ai-proteinase 
inhibitor and a2-macroglobulin. 
Elastin is a connective tissue component of a variety of tissues 
and organs. In addition to constituting the major part of the 
intimal layer of blood vessels, it provides elasticity to lung 
connective tissue, yellow tendon, cartilage, breast, and skin. 
Although the newly synthesized tropoelastin monomer is highly 
susceptible to degradation by a number of proteinases [1J, the 
turnover of mature cross-linked elastin fibers in adult mammals 
is very slow. Some degradation of elastin occurs in physiologic 
circumstances, including growth, wound healing, tissue remod­
eling, and pregnancy. The rate of elastin degradation and frag­
mentation is accelerated under a variety of clinical conditions, 
and agents that mediate destructive changes in the structural 
integrity of elastin will necessarily playa major role in such 
chronic diseases as pulmonary emphysema, atherosclerosis, and 
arthritis. Despite its obvious importance, little is known about 
the turnover of fully cross-linked elastin, and relatively few 
enzymes degrade it. Proteinases that can successfully use elastin 
as a substrate are of prokaryotic and eukaryotic origins. 
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The microfibrillar components of the elastin fibers do not 
resemble elastin, and are much more susceptible to proteolysis 
by a variety of trypsin-like and elastinolytic enzymes [2,3]. 
Indeed, the amorphous elastin fibers are often isolated by 
enzymatic treatment of elastin-containing tissues. However, the 
microfibrillar components may protect elastin from hydrolysis 
and thus the rate-limiting factor in elastin fiber breakdown in 
the presence of elastases may be the removal of the microfi­
brillar glycoprotein [3,4]. 
In the present paper we survey the elastinolytic enzymes that 
hav;) been implicated in physiologic and pathologic destruction 
of elastin fibers. We define as an elastase any proteinase that is 
able to solubilize and degrade insoluble elastin fibers alone. It 
is important to note, however, that while neither trypsin nor 
chymotrypsin alone can degrade elastin, these 2 enzymes com­
bined are elastinolytic, and such fortuitous combinations of 
enzymes may be significant in vivo. Additionally, elastin deg­
radation in vivo occurs slowly over years, and enzymes capable 
of very limited cleavage of elastin may still have significant 
functions in elastin fragmentation. 
MICIWBIAL ELASTASES 
The first description of an elastase was by Ewald, who in 
1890 demonstrated that ligamentum nuchae was digested when 
incubated with unsterile water [5] . In 1904 Eikman demon­
strated elastase activity in both Pseudomonas aeruginosa and 
P. fluorescens. He employed calf lung and ligamentum nuchae 
as substrates. Nineteen of 21 P. aeruginosa strains, 2 of 5 P. 
fluorescens strains, and Bacillis anthracis were positive for 
elastinolytic activity (reviewed in [6]). In 1918 Corper demon­
strated elastinolytic activity in Mycobacterium tuberculosis 
[6]. Oakley [6] extended the spectrum of elastinolytic activity 
in bacteria to Clostridium histolyticum, B. anthracoides, B. 
subtilis, B. lichteniformis, B. coagulans, B. cereus, B. pumilis, 
and B. mycoides. The properties of microbial elastases are 
shown in Table I. Fourteen strains of C. histolyticum produce 
elastase [6], as determined by clearing of elastin agar plates at 
37° C under anaerobic conditions. Dialyzed filtrates were much 
more active than crude filtrates against all forms of elastin. The 
elastase was inhibited by horse, human, ox, sheep, rabbit, and 
guinea pig sera. The properties of the elastase from Flavobac­
terium elastolyticum differ from elastases from B. subtilis, 
Pseudomonas species, and some species of Actinomycetaceae 
[7]. The pH optimum of the Flavobacterium elastase was 7.4, 
in contrast to a more alkaline pH optimum for the other 
bacteria and Actinomycetaceae. Sodium chloride, which is 
known to inhibit pancreatic elastase, inhibited all the elastases 
tested except for the Flavobacterium. Ozaki and Shiio [8] 
purified and crystallized an elastase from culture fluid of Fla­
vobacterium immotum. The enzyme showed activity against 
casein and soybean protein but not against keratin, collagen, or 
14 amino acid esters, including those that are typical substrates 
for pancreatic elastase and chymotrypsin. The enzyme selec­
tively hydrolyzed elastin when both elastin and albumin were 
present in the reaction mixture. Enzyme was inhibited by 1, 10-
phenanthroline and various heavy metals such as cadmium, 
lead, zinc, and mercury. Other inhibitors had no activity, in­
cluding DFP, soybean trypsin inhibitor, and iodoacetamide. 
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TABLE 1. Elastases of microbial origin 
Source 
Bacillus thermo-
philis (ther-
molysin) 
Pseudomonas 
aeroginosa 
Clostridium 
histolyticum 
Streptomyces gri­
seus (pronase) 
Actinomyces fra­
diae 
Nanizzia fulva 
Flavobacterium 
sp. 
Proteinase" 
class 
Metallo 
Metallo 
Metallo 
Serine 
Serine 
Cysteine 
Metallo 
I)roperties 
Broad spectrum, cleaves -Leu, 
-Ile, -Gly, -Val bonds; inbibited 
by phosphoramidon; degrades 
a,-PI 
Cleaves -Leu, -Ile bonds; degrades 
a,PI 
Inhibited by chela tors and serum 
(a2M'I); H202 does not inhibit 
Degrades N-Ac-(Ala) ,-methyl es­
ter 
M, 18,000, pI 9 
Inhibited by p-chloromercuriben­
zoate, urea, iodoacetate 
Insensitive to salt, M, 1:3,000, pI -
8.5, does not cleave ester sub­
strates of pancreatic elastase or 
chymotrypsin, inactive on ker­
atin, collagen 
------------------------� 
" All of these proteinases have neutral to alkaline pH optima. 
EDT A showed little effect on activity, but the enzyme was 
inhibited by high concentrations of sodium citrate. 
There are elastase-like enzymes (pronase) in Streptomyces 
griseus [9 J. These enzymes have alkaline pH optima and strong 
esterolytic activity when assayed on N -acetyl-L-alanyl-L­
alanyl-
·
L-alanine methyl ester. Both S. griseus and Sporangium 
species produced elastases with characteristics of serine pro­
teinases, whereas the elastases from Flavubacterium and Pseu­
dumonas resembled metalloproteinases. Pseudumunas elastase 
cleaves between a glycine and leucine residue and activity can 
be found if a peptide with an extended sequence of Ala-Gly­
Leu-Ala is used [10). 
Elastases as Virulence Facturs in Microbial Infectiuns 
The presence of an elastase in bacteria is of significant clinical 
importance because, in contrast to infections by such species as 
Streptucoccus pneumoniae, these organisms may cause a nec­
rotizing reaction that can lead to a severe subcutaneous cellu­
litis, cutaneous ulceration, or frank gangrene. This correlation 
between elastinolytic activity and virulence of bacteria in the 
skin is further supported by the work of Stewart [11] on the 
causative organism of foot rot, an ulcerative and erosive inflam­
matory lesion in sheep. Bacteruides nudusus plated on agar 
degrades elastin particles suspended in the agar. The presence 
of this elastinolytic activity correlated with the severity of 
infection in the sheep from which the organisms were cultured. 
The ability of P. aeruginusa to elaborate an elastase appears 
important in the pathogenesis of infections by this organism. P. 
aeruginusa is an opportunistic bacterium that is responsible for 
severe skin infections in burned and other immunocompromised 
patients. It is also responsible for a severe necrotizing pneu­
monia frequently seen in immunocompromised patients or chil­
dren with cystic fibrosis. The presence of extensive tissue de­
struction and hemorrhage are characteristics of Pseudomonas. 
Resulting septicemia is frequently the terminal course in many 
patients with severe infections. Early attempts to demonstrate 
a correlation between proteinase or elastase production and 
virulence using uncompromised hosts were unsuccessful. How­
ever, it has recently been shown that, in mice that have been 
compromised by a 15% body-surface-area burn [12J, the severity 
of infection and presence of bacteria in the bloodstream corre­
late with the presence of elastase production. This association 
with protease or elastase production and virulence suggests the 
possibility of employing immunoprophylaxis against Pseudu­
munas using the elastase as an antigen. 
In addition to tissue and blood vessel wall destruction, the 
elastase elaborated by Pseudumunas may be important in 
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modifying host response to the bacterium. Pseudomunas elas­
tase inactivates lXI-proteinase inhibitor (lX , -PI) [l:{j. A fragment 
of M, 5,000 was cleaved from the native lXI-PI molecule. By 
destruction of lXI-PI, endogenous as well as bacterial proteinases 
could be involved in tissue destruction. 
Histopathologically, Pseudomonas infections are often char­
acterized by a minimal host inflammatory response, and Pseu­
domonas organisms have been demonstrated in blood vessel 
walls with total absence of associated polymorphonuclear leu­
kocytes in tissue from human infections [14]. Complement 
factors 1, 3, 5, 8, and 9 were all inactivated in the presence of 
Pseudomonas elastase [15). This suggests a possible role for 
this enzyme in the non-inflammatory vasculitis seen in severe 
Pseudumunas infections. 
Elastase in Actinumyces, Dermatophytes, and Other Fungi 
Rippon and Varadi [16] have reviewed the production of 
elastase by fungi. Several dermatophytic fungi capable of in­
fecting hair, nails, and epidermis produce elastases. These in­
clude species of the genus Nanizzia, Arthruderma, Trichophy­
ton and Microsporum. The particular strains of Trichophyton 
that produce elastase are generally cultured from severe infec­
tions with alopecia and pitted scarring. The elastase from 
N. fulva had a pH optimum of 8 and was inhibited by p­
chloromercuribenzoate, urea, and iodacetate. It was not in­
hibited by EDTA or NaCl. This preliminary data suggested 
that this particular enzyme may be a cysteine proteinase. Elas­
tinolytic activity has also been detected in Coccidioides, and in 
Allesheria (the organism responsible for maduromycosis [my­
cetoma]) .  
O f  particular interest in terms of correlation between human 
infection or virulence and elastase production is the observation 
that the human strain of Entomophthora coronata produced 
elastase whereas the soil strain of this fungus did not. Actino­
myces fradiae also has an elastase. 
Elastase from Cercariae (Laruae) of Schistosoma mansoni 
Cercariae are the larval form of schistosomes (blood fluke 
worms), which initiate infection of the human host by penetra­
tion of intact human skin [17 J. This process is aided by the 
elaboration of proteolytic enzymes in the secretions from a set 
of glands within the larval head (the preacetabular glands). �he 
stimulus for release of cercarial secretions and for penetratlOn 
activity is skin lipid. After initial penetration, cercariae lose 
their tails and become a second larval form, the schistosomule. 
This larval form migrates through the dermis and enters the 
bloodstream via dermal vessels. Gazinelli, Ramalho-Pinto, and 
Pellegrino [18] first demonstrated elastinolytic activity in ho­
mogenates of whole cercariae, and Campbell et al [19 J found 
proteolytic activity against azocoll in secretions from preaceta­
bular glands. 
Recently we demonstrated elastase-like activity in cercarial 
secretions collected after stimulation of live cercariae by skin 
lipid (in preparation) . Partially purified enzyme had a pH 
optimum of 10 with Tris buffer, and 9 with glyc�ne/NaC?H 
buffer. The enzyme was calcium dependent, With optimal activ­
ity at 2 mM caicium. Its inhibition profile was consistent with 
a serine proteinase. The production of a proteinase with activity 
against elastin was confirmed by incubation of live cercariae 
with matrix containing elastin [3,4,19a]. 
ELASTASES AND THE PATHOGENESIS OF VENOMS 
The general proteolytic activity associated with snake ven­
oms was noted by Lacerda almost one century ago [20). Only 
recently have elastases been identified among these venom 
proteinases [21). The data shown in Table II show that not all 
snakes possess a venom elastase. In general, the venom of 
rattlesnakes, pit vipers, and puff adders has potent elastase 
activity. Because 1,10-phenanthroline (a metalloproteinase in­
hibitor) is the best inhibitor of snake venom elastase, it is likely 
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TARLE II. f;;lastinoZytic activity in variolls ('enoms 
Sp('cil'S name (tri\'ial 
name) 
Crotaills adamantells 
(Eastern diamond-
back rattlesnake) 
Bothrops }ar(lraca 
(South American pit 
viper) 
Bilis arietans (puff ad­
der) 
N(z;a naja (common In­
dian cobra) 
Units"/mg" 
470 
710 
800 
5.5 
c;, I nh ibit ion' 
1 mM 1, lO-
I mM I'MSF phenanthro-
line 
:3:3 100 
25 >% 
8 >95 
0 68 
Heloderma horridllm 1.1 0 27 
(gila monst.er) 
Bllfo regillaris (African 0.1 0 0 
toad) 
Apis mellifera (honey 0.2 0 0 
bee) 
VesPllla germinica (yel- 12.4 :3(; 0 
low jacket) 
Lactrodectlls mactans" 1.9 0 0 
(black widow spider) 
Physalia physalia (1'01'- 1.1 0 0 
tugllese man-or-war) --- -- -
" Elastinolytic activity was determined with an insoluble 'H-elastin 
substrate. O�e unit of a�tivity is defined as the degradation of 1.0 Ilg of 
elastin/b at :17°C in 10 mM Tris-HCl, 5 mM CaCL, pH 8.0 [2]. 
I, The elastinolytic activity was normalized to activity per milligram 
dry weight of lyophilized wbole venom. 
, Phenylmethanesulfonylfluoride (PMSF), an inhibitor of serine pro­
teinases, 
'
and 1, lO-phena�throline, an inhibitor of metalloproteinases, 
were each dissolved separately al 1 mM in ethanol. Inhibition was 
expressed relative to solvent controls. 
" L. mactans venom elastinolytic activity is expressed as units per 
set of venom glands that were homogenized in saline. 
that these proteinases are metalloproteinases. However, be­
cause some serine proteinase inhibitors are also effective, to a 
lesser degree, there may be a serine proteinase component to 
the elastinolytic activity. Indeed, until the proteinases involved 
are purified it is not possible to distinguish an individual snake 
venom elastase from the cooperative activities of more than 
one proteinase that would result in elastinolysis. 
The elastinolytic activity in snake venoms has been used as 
a taxonomic marker and has proven significant at the family 
level [19]. As demonstrated in Table II, not all snakes have 
elastinolytic activity. The cobra (Naja naja) has an extremely 
toxic venom with little or no elastinolytic activity. Other ven­
omous reptiles such as the gila monster (Heloderma horridum) 
also lack elastinolytic activity. In one study [21] elastase activity 
was detected in all venom of 12 Crotalidae (rattlesnakes) , all of 
5 Viperidae (true vipers), but in only 1 of 8 Elapidae (mambas 
and true cobras). Many other snake venoms have proteolytic 
activity but lack elastinolytic activity [22]. 
Clinical correlation of strong elastinolytic activity with the 
management of snake bites is possible. Venoms of Crotalidae 
and Viperidae can mediate severe local tissue degradation that 
may not always be prevented by the administration of antivenin 
[22 J. Venoms of the Elapidae and the Hydrophiidae (sea snakes) 
act via their neurotoxins and mediate little tissue destruction. 
Because of the differences in the tissue damage associated with 
different snake venoms, it becomes essential to identify the 
attacking snake if possible. If the attacking reptile is a rattle­
snake or viper, diffusing connective tissue damage may be 
prevented by the application of a wide, mildly constricting 
tourniquet [22,23]. 
Proteolytic and elastinolytic activity is not common in the 
venoms of invertebrates. Of the representative arthropod ven­
oms that we have assayed for elastinolytic activity, bee venom 
and black widow spider venom were negative and yellow jacket 
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venom had only a trace of activity (Table II). Although the 
yellow jacket activity was low, it was more elastinolytic than 
the cobra or gila monster venom. The yellow jacket elastinolytic 
activity was not inhibited by a metalloproteinase inhibitor but 
was slightly inhibited by a serine proteinase inhibitor. 
Even though many venoms lack intrinsic elastinolytic capa­
bility, it is possible that, as a result of inflammation, they could 
cause indirect elastinolysis through the host inflammatory re­
sponse. Macrophages and/or neutrophils, cells that have the 
potential to release elastase, could be sequestered to the wound 
site and cause elastin degradation. 
MAMMALIAN ELAST ASES 
Pancreatic Elastases 
There are 2 elastases in mammalian pancreas (Table III). 
The best-characterized elastase, pancreatic elastase I from por­
cine pancreas, is produced as a zymogen, proelastase, in pan­
creatic f3-cells and is activated in the intestine by trypsin [24]. 
It solubilizes elastin and hydrolyzes bonds in polypeptides and 
synthetic ester and amide substrates, and its preference for the 
residue contributing the carboxyl group is Ala, Leu, Gly, Val, 
lie. The catalytic activity of pancreatic elastase is enhanced by 
increasing the peptide length to 4 residues, but the P'3 site 
cannot accommodate Pro, in marked contrast to granulocyte 
elastase. Pancreatic elastase is inhibited by DFP, elastatinal, 
chloromethyl ketone substrate analogues (e.g., Ac-Ala-Ala-Pro­
Ala-CH:!Cl), aIPI, a:!M, and turkey ovomucoid, but not soybean 
trypsin inhibitor or aprotinin. 
Human pancreas contains much less elastinolytic activity 
than porcine, and it resembles pancreatic elastase II. Pancreatic 
elastase II digests elastin by cleavage of Leu-, Phe-, Tyr- bonds 
and by cleavage of substrates of chymotrypsin. It is not in­
hibited by turkey ovomucoid. Human pancreas also contains 
protease E, an enzyme that has little or no activity on elastin, 
but cleaves casein, and hydrolyzes the ester and amide sub­
strates of elastase 1. It is inhibited by (X 1 PI. 
Granulocyte Elastase 
The circulating polymorphonuclear leukocyte or neutrophilic 
granulocyte is the characteristic cell of the acute inflammatory 
response in mammals. Many of its functions in host defense 
rely on the phagocytosis and intracellular degradation of par­
ticles and molecules using a complex assortment of lysosomal 
hydrolases and proteinases. Proteolytic activity in leukocytes 
was first recognized by Metchnikoff [25]. In the past few years 
it has been recognized that the granulocyte proteinases possess 
the potential for mediating damage to the host organism as well 
as the invader. An enzyme with elastinolytic activity has proved 
among the most interesting of these agents. In 1968 Janoff and 
Scherer [26] showed that human neutrophils contain a neutral 
proteinase in their granules that can degrade elastin. They 
suggested that this enzyme might play a role in the development 
of elastic lamina disruption in neutrophil-mediated arteritis. An 
early assumption was that the elastinolytic activity of the 
granulocyte enzyme was likely to be fortuitous and that some 
other defensive role would be found or that some foreign 
substrate of greater significance would be identified. 
Granulocyte elastase is a basic glycoprotein with a molecular 
weight of approximately 25,000 daltons [24,27-29]. It can be 
visualized by native acid polyacrylamide gel electrophoresis as 
a multiple band complex with the differing mobilities. Granu­
locyte elastase is active against ligamentum nuchae elastin, 
rodent, canine, and human lung elastin, hemoglobin, casein, 
bacterial cell wall proteins, and a number of low molecular 
weight amide and ester derivatives of alanine. The N-terminal 
sequence of granulocyte elastase shows strong homology with 
pancreatic elastase, although there are clear differences be­
tween the enzymes in specificity and substrate sensitivity 
[24,28]. It cleaves pep tides to the carboxyl amino acid residues, 
preferring Val-, in contrast to pancreatic elastase I, which 
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TABLE III. Distribution and characteristics of mammalian eZaslinoZytic proteinases" 
�--- � �  -- ----
Enzyme EC number Proteinase ,source class H t' 
Cleavage :-;pecifi('itv and major sub-p op ,Jmum st rates ot her than elast in Inhihitors 
Molecular 
proppl'tips 
Pepsin A :3.4.23.1 Aspartic Porcine gastric 1.8-2.2 Cleaves Phe-, Leu-, Trp- M, :14,i)OO 
mucosa bonds 
Pancreatic 3.4.21.11" Serine Porcine pan- 8.5 Cleaves Ala-, Leu-, Gly-, '" PI, lI" M, turkey M, 25,900 
elastase I creas Val-, Ile-, Ac-(Ala},- ovomucoid, Ac-
OPhNOe, BOC-Ala- (Ala),-CHe CI 
OPhNO", 2 -Ala- 20Nap 
Pancreatic 3.4.2.21- Serine Porcine pan- Cleaves Leu-, Pbe-, Tyr-, n,PI, "eM, not tur- M,26,i)OO 
elastase II creas Ac-Tyr-OEt key ovomucoid; 
Tos-Phe-CHeCI 
Granulocyte 3.4 . 21. 11" Serine Azurophil 8.5 Cleaves Val-, Ala-, Ac- 0, PI, "eM, Mt'O-Suc- M, :30,000 
elastase granules of (Ala),-NPhNOe, BOC- Ala-Ala-Pro-Val-
PMN Ala-OPhNOe, MeO-Suc- CHeCI 
Ala-Ala-Pro-Val-NMec 
Tissue :3.4.21.- Serine ('!) Porcine and Neutral Suc-(Ala),-NPhNOe H,PI, oeM M,2:3,OOO 
elastase human aorta, 
human 
breast 
Macrophage 3.4. 24.- Metallo Secreted by 8.0 Cleaves -Leu, -Ile bonds, ""M. TI M,22,OOO 
dastase mouse, rab- '" PI, fibrinogen, immuno-
bit, gu inea globulins 
pig macro-
phages 
-----
" Data summarized from Barrett and McDonald [24J. Abbrt'viations: (I, PI, H,-proteinase in hibitor; HeM, lle-macrog-lobulin; I'MN. polymorpho­
nuclear leukocvtes; TI, tissue inhibitors, not well characterized. 
" EC numbe� shared by some mammalian elastases. 
prefers Ala-. It accommodates a Pro residue in its p'a site and 
derivatives of Ala-Pro-Ala-Ala inhibit granulocyte elastase, but 
not pancreatic elastase. Derivatives of Ala-Ala-Pro-Val are 
preferred substrates, and chloromethyl ketone derivatives of 
this tetrapeptide are efficient inhibitors. It is inhibited by DFP, 
elastatinal, elasnin, aIPI, and O'Tmacroglobulin (O'"M). Soybean 
trypsin inhibitors and aprotinin, which do not inhibit pancreatic 
elastase, are inhibitory for granulocyte elastase. 
We have found that granulocyte elastase is packaged within 
the azurophil granule in a native complex of much higher 
molecular weight than previously described; this high molecular 
weight complex is converted to the more classic elastase upon 
incubation at a7°C [ao]. In cells derived from a patient with 
pro myelocytic leukemia the enzyme is found virtually exclu­
sively in this form. 
A role for neutrophil elastase in human diseases has been 
suggested in the elastin degradation associated with pulmonary 
emphysema, arthritis, and certain skin diseases; in addition, 
inflammatory processes leading to localized protein breakdown, 
such as arthritis, have been suggested to be at least partially 
mediated by elastase [31]. In animal models of emphysema, 
which have used instillation of various proteinases to create an 
analogue to the human disease, only proteinases with elastin­
olytic ability are capable of inducing emphysema-like lesions. 
The role of granulocyte elastase in skin disease has been less 
well studied. Although many dermatologic processes involve 
fragmentation and disappearance of dermal elastic fibers, no 
association of these diseases with neutrophil elastase or even 
neutrophil infiltration has been made. The anetodermas, dis­
eases characterized by isolated loss of dermal elastic fibers, are 
often preceded by an inflammatory reaction, especially the 
anetoderma of Jadassohn-Pellizari [32]. However, no direct 
evidence has been sought correlating this elastin degradation 
with the presence of neutrophil elastase, and anetoderma has 
been found in the absence of overt inflammation or following 
mononuclear cell infiltrative processes. In light of the variety of 
diseases associated with dermal elastin disruption, direct inves­
tigation of the possible role of granulocyte elastase might prove 
fruitfuL 
Macrophage Elastase 
Inflammatory murine macro phages secrete an elastase that 
has been purified and characterized as a metalloproteinase 
[33]. As with other tissue proteinases, the majority of the 
murine macrophage elastase is secreted in an inactive form, 
probably in complex with an inhibitor. The inhibitor-elastase 
complex can be dissociated by low ionic strength dialysis and 
by an SDS-modified elastin assay. This amplification by dialysis 
and SDS is effective only on crude macrophage-conditioned 
medium, and these methods do not activate the purified mac­
rophage elastase. 
As a metalloproteinase, macrophage elastase is catalytically 
distinct from other mammalian (granulocyte and pancreatic) 
elastases, which are serine proteinases. Despite this difference, 
macrophage elastase and the serine elastases fully degrade 
cross-linked insoluble elastin as well as lathrytic aortic elastin. 
However, the nature of the proteolytic cleavage differs. The 
macrophage elastase primarily cleaves on the amino side of 
leucyl residues [33,34], whereas the granulocyte elastase cleaves 
on the carboxyl side of valyl and alanyl residues [24,28] and the 
pancreatic elastase cleaves carboxyl to alanyl, valyl, and glycyl 
residues [24]. This difference in amino acid sequence recognized 
by the macrophage metallo-elastase and the 2 serine elastases 
may account for their apparent differences in the extent of 
elastinolysis. Elastin is rich in alanyl, glycyl, and valyl residues 
with a lesser endowment of leucyl residues. Thus, the amino 
acid sequence of elastin indicates that it would not be the 
preferred substrate for macrophage elastase. For these reasons, 
the commonly used synthetic elastin-like substrates, succinyl­
L-alanyl-L-alanyl-alanine-p-nitroanalide and t-HOC-L-alanine­
p-nitrophenyl-ester, are not suitable substrates for macrophage 
elastase [33] and cannot be assumed to be a sufficient means of 
assay for all elastases. Similarly, the active site-specific chloro­
methyl ketone inhibitors of granulocyte elastase and pancreatic 
elastase (e.g., derivatives of (Ala).,) are ineffective against mac­
rophage elastase. 
Macrophage elastase is a broad-range proteinase capable of 
degrading other tissue substrates such as fibrinogen, immuno­
globulin G subclasses, fibronectin, and myelin basic protein 
[33,35]. This is not unusual for an elastase because all of the 
elastases that have been purified are capable of degrading other 
protein substrates. What macrophage elastase and the serine 
elastases do not have in common are their respective suscepti­
bilities to natural proteinase inhibitors. In addition to its im­
munity to the effects of soybean trypsin inhibitor, macrophage 
elastase is not inhibited by alPI [33]. 
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Although macrophages secrete elastase, it has been J?ore 
difficult to demonstrate that macrophages degrade elastm m 
vivo. Live macrophages degrade elastin-rich extracellular mat­
rices by circumscribed extracellular proteolysis followed by 
degrad�tion of fragments to amino acids and oligopeptides 
within lysosome!" [:3,4]. This conclusion is supported by mo�­
phologic observation of the dissolution of the insoluble matnx 
components, and biochemical demonstration of significant ma­
trix degradation with millimeter distances separating cells from 
the connective tissue proteins. In addition, macrophages that 
secrete elastase and other proteinases at different rates, as a 
result of differentiation along different pathways, degraded 
elastin proportionately, indicating a role for macrophage elas­
tase in this process. There are several lines of evidence that a 
portion of the macrophage-mediated degradation of elastin is 
restricted to the pericellular zone of the macrophage. Although 
the elastin-degradative potential of medium conditioned by 
macrophages is similar to that of cultured cells, scanning elec­
tron microscopy revealed localized degradation near J?acro­
phages (Fig 1). These conclusions are supported by expenments 
indicating that elastin degradation took place slightly more 
rapidly when cells were in contact with the matrix than ...;hen 
the matrix was separated from the macrophages [3,4]. Some 
secreted elastase may be relatively inaccessible to macromolec­
ular inhibitors. Bec;use local control is an important factor in 
elastin degradation by macrophages in culture, where the ex­
tracellular fluid is in excess, it is likely that it plays an even 
more significant role in vivo. 
Degradation of Elastin by Implanting Rmbryos and by 
Tumor Cells 
There are at least 2 experimental systems reported in which 
extracellular elastin degradation has been observed in the ab­
sence of demonstrable elastinolytic enzyme production. 
During implantation the embryo traverses the uterine epi­
thelium and then anchors in the uterine connective tissue. To 
determine whether trophoblast can degrade components of 
normal extracellular matrix, mouse blastocysts were cultured 
on a matrix that contained elastin, collagen, and glycoproteins 
[36]. The embryos attached to the matrix and trophoblast 
spread out over the surface. Starting on Day 6 of cul�ure t?ere 
was a release of elastin-, collagen-, and glycoprotem-derlved 
peptides and amino acids into the medium. On Day 7 of culture 
there were areas where individual cells had separated from one 
another to reveal the underlying substratum, cleared of all 
elastin and other components of matrix in parallel. The entire 
area underneath the trophoblast outgrowth had been cleared 
of matrix. Scanning electron microscopy (Fig 2) and time-lapse 
FJ(; I. Scanning electron micrograph of a lhioglycollate-elicited 
mouse peritoneal macrophage (mac) cultured in serum-free medium 
for 72 hr on the elastin-rich extracellular matrix secreted by smooth 
muscle cells [:3,4]. Nearly intact matrix (M) is seen beyond the macro­
phage. In the area near the macrophage the matrix is reduced (*)and 
only a few elastin particles and some collagen fibers remain. Bar IS 10 
/Lnlo 
Vol. 79, Supplement 1 
FIG 2. Scanning electron micrograph of a mouse embryo cultured 
on an elastin-rich matrix for 8 days (12 equivalent gestational days). 
Where the trophoblast cells (tb) have separated. clearing of elastin is 
seen (*). The embryo proper (e) does not digest the matrix r:36]. Beyond 
the edge of the trophoblast the matrix (M) is intact. Bar is 200 /L1ll. 
cinematography confirmed that the digestion of matrix was 
highly localized, taking place only underneath the trophoblast 
outgrowth. There was no evidence of digestion of the matrix at 
the periphery of the trophoblast outgrowth and no elastase 
activity was detected in the medium. The digestion of the 
matrix was not dependent on plasminogen, thus ruling out a 
role for plasminogen activator. It was not inhibited by inhibitors 
of known proteinases, including soybean trypsin inhibitor, leu­
peptin, or EDT A. 
Human metastatic tumor cells also degrade elastin [:37]. As 
with trophoblast, no elastinolytic enzymes were detected in the 
cells or their conditioned medium, and yet they effectively 
degraded this component of the extracellular matrix. The 
nature of the enzymes mediating this process is unknown, 
although these cells in culture degraded the extracellular mat­
rices to amino acids. The precise localization of the elastase 
solubilization is not known. Endocytosis of insoluble matrix 
components would be virtually impossible without limit.ed ex­
tracellular proteolysis. Understanding of the regulation of this 
degradation is complicated by the observation that neutral 
proteinases are secreted by cells along with proteolytic inhibi­
tors [4,33]. In addition to extracellular digestion by neutral 
proteinases and intracellular digestion by lysosomal hydrolases, 
there is a third location for matrix solubilization at the cell 
surface and in the pericellular space. This zone differs from 
other extracellular sites because (a) local saturation of protein­
ase inhibitors may take place there, (b) cellular metabolism, 
including lactate production, could lower local pH so that 
lysosomal hydrolases could participate in matrix degradation, 
and (c) cell surface-bound enzymes could participate directly in 
degradation. 
ai-PROTEINASE INHIBITOH AND THE REGULATION 
OF ELASTINOL YTIC ACTIVITY 
alPI is the primary regulator of granulocyte and pancreatic 
elastase activities in vivo. Deficiencies in alPI have been impli­
cated in the early onset of emphysema and childhood cirrhosis 
[38). The local inactivation of aIPI, as seen in cigarette smoking 
models [3 1], is thought to lead to extensive elastin degradation. 
Any agent that can inactivate alPI must be considered when 
evaluating the course of elastin degradation. Macrophage elas­
tase is such an agent because not only is it immune to inhibition 
by aIPI, but it can proteolytically degrade and inactivate alPI 
[:39 J. This ability to permanently inactivate an inhibitor of other 
elastases, and other serine proteinases in general, gives macro­
phage elastase the potential for both direct and indirect destruc­
tion of elastin. 
The ability to degrade alPI is found in elastinolytic enzymes 
from various species, although it is unique to macrophage 
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elastase in mammals. Pseudomonas elastase, a metallopro­
teinase like macrophage elastase, can degrade a lPI [1:3] and 
amplify the Pseudomonas ability to destroy elastin by releasing 
normally inhibited host serine elastases via the inactivation of 
a l P!. The degradation of a lPI may also be the consequence of 
the action of certain reptilian elastases. Metalloproteinases 
found in the venoms of some Crotalid, Viperid, and Colubrid 
snakes degrade a lPI [40]. 
PEPTIDASES CLEAVING ELASTIN-LIKE ARTIFICIAL 
SUBSTRATES, BUT NOT ELASTIN 
There is considerable confusion in the literature about "elas­
tases" because of the widespread use of chromogenic ester and 
amide substrates having alanyl and valyl residues. A number of 
esterases and peptides cleave these substrates but have no 
demonstrable activity against insoluble elastin [24,28,:3:3]. Hu­
man alveolar macro phages have been shown to contain an 
enzyme that is a potent esterase on substrates derived from 
(Ala) " although this is not an elastase. Similarly, alanine ester­
ases in human synovial fluid and protease E from human 
pancreas are not elastases. Elastase-like esterases have also 
been demonstrated in endoplasmic reticulum membranes of 
human polymorphonuclear leukocytes and dog pancreas, and 
in mitochondria. 
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